# NDV-HXP-S Vaccine Clinical Trial (COVIVAC)

> **NCT05940194** · PHASE2 · COMPLETED · sponsor: **Institute of Vaccines and Medical Biologicals, Vietnam** · enrollment: 374 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** COVIVAC vaccine

## Key facts

- **NCT ID:** NCT05940194
- **Lead sponsor:** Institute of Vaccines and Medical Biologicals, Vietnam
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-11
- **Primary completion:** 2021-10-18
- **Final completion:** 2022-03-11
- **Target enrollment:** 374 (ACTUAL)
- **Last updated:** 2025-01-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05940194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05940194, "NDV-HXP-S Vaccine Clinical Trial (COVIVAC)". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05940194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*